Pasteurised Donor Human Milk Supplementation for Term Babies

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age0-48
SponsorThe University of Queensland

About this trial

PRESENT is a multi-center randomised controlled trial that aims to assess whether access to pasteurized donor human milk as supplementary nutrition in the first five days of life for term infants born to women with diabetes in pregnancy reduces the proportion of infants who are admitted to a neonatal unit for management of hypoglycemia compared with current standard hospital care. The trial will also assess other important outcomes including breastfeeding rates, maternal mental health, and infant cow's milk allergy.

There will be two treatment arms. In the intervention arm, PDHM will be made available to infants from randomisation until day 5 of life. Infants allocated to the control arm will receive care as per local unit policy, including supplemental nutrition as recommended by the treating clinician. After hospital discharge, participants will be asked to complete an electronic questionnaire at 2 \& 6 weeks and 6 \& 12 months after birth. Questionnaires will assess infant feeding practices, maternal quality of life \[including anxiety and depression symptoms and health-related quality of life\] along with infant cow's milk allergy symptoms.

Eligibility criteria

Qualifiers

Mother is >18 years at the time of consent

Mother has diabetes in pregnancy (type 1, type 2 or gestational diabetes)

Mother intends to breastfeed for at least 6 weeks at the time of consent.

Infant is born at ≥ 37 weeks and weighs > 2.5kg

Disqualifiers

Multiple pregnancy

Mother has a condition that precludes maternal breast milk consumption e.g. HIV, receiving chemotherapy

Infant has clinically significant congenital abnormality interfering with effective breastfeeding or breast milk consumption (e.g., cleft lip and palate, metabolic disorder) and/or requiring immediate care in a neonatal unit (e.g., congenital heart disease).

Infant has received infant formula prior to randomisation.

Trial design

Treatments tested in this trial

  • Standard care Cow's milk based formula
  • Dietary Supplement: PDHM Pasteurised Donor Human Milk

Treatment groups

1,444 Participants
are divided into 2 treatment groups

Sponsors and collaborators

The University of Queensland

Lead sponsor

Murdoch Childrens Research Institute

Collaborator

La Trobe University

Collaborator

University of Melbourne

Collaborator

South Australian Health and Medical Research Institute

Collaborator

Australian Red Cross Lifeblood

Collaborator

Monash University

Collaborator

The Royal Women Hospital

Collaborator

Frances Perry House (Ramsay Health)

Collaborator

Ramsay Hospital Research Foundation

Collaborator